Cincinnati Childrens Hospital MC

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia1 trial
• IgA nephropathy1 trial

Phase

• Phase 32 trials

Status

• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials

Running trials

• Recruiting

  Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  NCT07498335· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• IgA nephropathy1 recruiting

Closed trials

• Recruiting

  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  NCT05682378· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals